liranaftate has been researched along with Disease Models, Animal in 3 studies
piritetrate: structure given in first source
Disease Models, Animal: Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the effect of the thiocarbamate antifungal agent liranaftate on inflammation and itchiness, footpad edema by phorbol 12-myristate 13-acetate (PMA) and the paw-licking accompanying by perceptual stimuli by compound 48/80 were examined." | 3.78 | [Suppression of experimental footpad inflammatory reaction by anti-fungal agent liranaftate in mice]. ( Abe, S; Ishijima, S; Maruyama, N, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM | 1 |
| Yasgar, A | 1 |
| Teramoto, T | 1 |
| Lee, MH | 1 |
| Dorjsuren, D | 1 |
| Eastman, RT | 1 |
| Malik, N | 1 |
| Zakharov, AV | 1 |
| Li, W | 1 |
| Bachani, M | 1 |
| Brimacombe, K | 1 |
| Steiner, JP | 1 |
| Hall, MD | 1 |
| Balasubramanian, A | 1 |
| Jadhav, A | 1 |
| Padmanabhan, R | 1 |
| Simeonov, A | 1 |
| Nath, A | 1 |
| Maruyama, N | 2 |
| Abe, Y | 1 |
| Hisajima, T | 1 |
| Hayama, K | 1 |
| Abe, S | 2 |
| Ishijima, S | 1 |
3 other studies available for liranaftate and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Dr | 2020 |
[Suppression of experimental inflammation by anti-fungal agent liranaftate in mice].
Topics: Administration, Topical; Animals; Antifungal Agents; Disease Models, Animal; Dose-Response Relations | 2010 |
[Suppression of experimental footpad inflammatory reaction by anti-fungal agent liranaftate in mice].
Topics: Administration, Topical; Animals; Antifungal Agents; Behavior, Animal; Cytokines; Disease Models, An | 2012 |